Vestal Point Capital »

Atara Biotherapeutics shares owned by Vestal Point Capital

Quarter-by-quarter ownership of Atara Biotherapeutics (ATRA) shares owned by Vestal Point Capital from 13F filings

Historical chart of Vestal Point Capital investment in Atara Biotherapeutics

Tip: Access up to 7 years of quarterly data

All positions including Atara Biotherapeutics held by Vestal Point Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Atara Biotherapeutics by Vestal Point Capital

Quarter filed Position value Share count Share price at filing
2024-06-30 $952k 112k 8.50

More positions owned by Vestal Point Capital

Jazz Pharmaceuticals Shs Usd (JAZZ)
Cytokinetics Com New (CYTK)
Ascendis Pharma A/S Sponsored Adr (ASND)
Ultragenyx Pharmaceutical (RARE)
Globus Medical Cl A (GMED)
Insmed Com Par $.01 (INSM)
BeiGene Sponsored Adr (BGNE)
Soleno Therapeutics (SLNO)
EXACT Sciences Corporation (EXAS)
Arcellx Common Stock (ACLX)
Immatics NV SHS (IMTX)
Janux Therapeutics (JANX)
Astria Therapeutics (ATXS)
Kalvista Pharmaceuticals (KALV)
Savara (SVRA)

View all positions for Vestal Point Capital

Top funds holding Atara Biotherapeutics

Redmile Group
EcoR1 Capital
Citadel Advisors
Bank of America Corporation
Vanguard Group
Centiva Capital
Acadian Asset Management
Millennium Management
Vestal Point Capital
Qube Research & Technologies
Tang Capital Management
Woodline Partners
BlackRock
Geode Capital Management
Renaissance Technologies

View all funds holding Atara Biotherapeutics